Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Atrion Corporation stock
Learn how to easily invest in Atrion Corporation stock.
Atrion Corporation is a medical instruments & supplies business based in the US. Atrion Corporation shares (ATRI) are listed on the NASDAQ and all prices are listed in US Dollars. Atrion Corporation employs 636 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Atrion Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ATRI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Atrion Corporation stock price (NASDAQ: ATRI)Use our graph to track the performance of ATRI stocks over time.
Atrion Corporation shares at a glance
|Latest market close||$662.06|
|52-week range||$576.88 - $803.41|
|50-day moving average||$718.16|
|200-day moving average||$670.20|
|Wall St. target price||$300.00|
|Dividend yield||$7.2 (1.13%)|
|Earnings per share (TTM)||$17.70|
Buy Atrion Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Atrion Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Atrion Corporation price performance over time
|1 week (2022-01-12)||-3.08%|
|1 month (2021-12-17)||-3.21%|
|3 months (2021-10-18)||-3.91%|
|6 months (2021-07-20)||7.59%|
|1 year (2021-01-20)||-6.80%|
|2 years (2020-01-17)||-6.43%|
|3 years (2019-01-18)||765.82|
|5 years (2017-01-20)||39.59%|
Is Atrion Corporation stock undervalued or overvalued?
Valuing Atrion Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Atrion Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Atrion Corporation's P/E ratio
Atrion Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Atrion Corporation shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Atrion Corporation's EBITDA
Atrion Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.2 million.
The EBITDA is a measure of a Atrion Corporation's overall financial performance and is widely used to measure a its profitability.
Atrion Corporation financials
|Revenue TTM||$157 million|
|Operating margin TTM||22%|
|Gross profit TTM||$66.2 million|
|Return on assets TTM||8.11%|
|Return on equity TTM||13.53%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Atrion Corporation share dividends
Dividend payout ratio: 40.52% of net profits
Recently Atrion Corporation has paid out, on average, around 40.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.13% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Atrion Corporation shareholders could enjoy a 1.13% return on their shares, in the form of dividend payments. In Atrion Corporation's case, that would currently equate to about $7.2 per share.
While Atrion Corporation's payout ratio might seem fairly standard, it's worth remembering that Atrion Corporation may be investing much of the rest of its net profits in future growth.
Atrion Corporation's most recent dividend payout was on 14 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 November 2021 (the "ex-dividend date").
Have Atrion Corporation's shares ever split?
Atrion Corporation's shares were split on a 3:2 basis on 2 December 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Atrion Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Atrion Corporation shares which in turn could have impacted Atrion Corporation's share price.
Atrion Corporation share price volatility
Over the last 12 months, Atrion Corporation's shares have ranged in value from as little as $576.8842 up to $803.4142. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atrion Corporation's is 0.0791. This would suggest that Atrion Corporation's shares are less volatile than average (for this exchange).
Atrion Corporation overview
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, mixes critical drugs, controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors.
Atrion Corporation in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Atrion (NASDAQ:ATRI) May Have Issues Allocating Its Capital
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Frequently asked questionsWhat percentage of Atrion Corporation is owned by insiders or institutions?
Currently 22.206% of Atrion Corporation shares are held by insiders and 66.768% by institutions. How many people work for Atrion Corporation?
Latest data suggests 636 work at Atrion Corporation. When does the fiscal year end for Atrion Corporation?
Atrion Corporation's fiscal year ends in December. Where is Atrion Corporation based?
Atrion Corporation's address is: One Allentown Parkway, Allen, TX, United States, 75002-4211 What is Atrion Corporation's ISIN number?
Atrion Corporation's international securities identification number is: US0499041053 What is Atrion Corporation's CUSIP number?
Atrion Corporation's Committee on Uniform Securities Identification Procedures number is: 012005104
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert